Geneos Wealth Management Inc. Has $708,000 Stake in American Healthcare REIT, Inc. $AHR

Geneos Wealth Management Inc. decreased its position in American Healthcare REIT, Inc. (NYSE:AHR) by 12.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 23,365 shares of the company’s stock after selling 3,315 shares during the quarter. Geneos Wealth Management Inc.’s holdings in American Healthcare REIT were worth $708,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of AHR. Invesco Ltd. raised its stake in shares of American Healthcare REIT by 1,543.1% in the 1st quarter. Invesco Ltd. now owns 5,022,455 shares of the company’s stock valued at $152,180,000 after purchasing an additional 4,716,792 shares during the period. Alliancebernstein L.P. raised its stake in shares of American Healthcare REIT by 350.7% in the 1st quarter. Alliancebernstein L.P. now owns 4,559,365 shares of the company’s stock valued at $138,149,000 after purchasing an additional 3,547,635 shares during the period. Vanguard Group Inc. raised its stake in shares of American Healthcare REIT by 22.4% in the 1st quarter. Vanguard Group Inc. now owns 18,795,192 shares of the company’s stock valued at $569,494,000 after purchasing an additional 3,437,861 shares during the period. Nuveen LLC acquired a new stake in shares of American Healthcare REIT in the 1st quarter valued at about $68,097,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of American Healthcare REIT in the 1st quarter valued at about $13,384,000. Institutional investors and hedge funds own 16.68% of the company’s stock.

Insider Transactions at American Healthcare REIT

In related news, CIO Stefan K.L. Oh sold 3,860 shares of American Healthcare REIT stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $36.10, for a total transaction of $139,346.00. Following the completion of the transaction, the executive owned 95,671 shares in the company, valued at approximately $3,453,723.10. This trade represents a 3.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Mark E. Foster sold 3,850 shares of American Healthcare REIT stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $41.89, for a total value of $161,276.50. Following the transaction, the executive vice president owned 59,100 shares of the company’s stock, valued at $2,475,699. The trade was a 6.12% decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.92% of the company’s stock.

Wall Street Analysts Forecast Growth

AHR has been the topic of several recent research reports. Baird R W raised American Healthcare REIT to a “strong-buy” rating in a research note on Thursday, July 17th. Robert W. Baird initiated coverage on American Healthcare REIT in a research report on Friday, July 18th. They issued an “outperform” rating and a $41.00 target price on the stock. Truist Financial lifted their target price on American Healthcare REIT from $44.00 to $46.00 and gave the company a “buy” rating in a research report on Tuesday, August 26th. Morgan Stanley reaffirmed an “overweight” rating on shares of American Healthcare REIT in a research report on Wednesday, September 3rd. Finally, Royal Bank Of Canada lifted their target price on American Healthcare REIT from $39.00 to $45.00 and gave the company an “outperform” rating in a research report on Wednesday, August 13th. One equities research analyst has rated the stock with a Strong Buy rating and ten have assigned a Buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $41.89.

American Healthcare REIT Trading Down 0.2%

American Healthcare REIT stock opened at $42.66 on Friday. American Healthcare REIT, Inc. has a 52 week low of $23.66 and a 52 week high of $43.52. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.48 and a current ratio of 0.48. The stock has a market capitalization of $7.19 billion, a P/E ratio of -193.89, a PEG ratio of 2.19 and a beta of 1.09. The stock has a 50-day simple moving average of $39.97 and a 200 day simple moving average of $35.04.

American Healthcare REIT (NYSE:AHR) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.02. American Healthcare REIT had a negative return on equity of 1.43% and a negative net margin of 1.56%.The business had revenue of $542.50 million during the quarter, compared to analysts’ expectations of $539.49 million. During the same quarter last year, the company posted $0.33 earnings per share. American Healthcare REIT’s quarterly revenue was up 7.5% on a year-over-year basis. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. Analysts expect that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current year.

American Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, July 18th. Investors of record on Monday, June 30th were issued a dividend of $0.25 per share. The ex-dividend date was Monday, June 30th. This represents a $1.00 dividend on an annualized basis and a yield of 2.3%. American Healthcare REIT’s dividend payout ratio (DPR) is presently -454.55%.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.